Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Genetown entities : Novo nordisk a::S save search
Beta Bionics Announces FDA Clearance for the Use of a Prefilled Insulin Cartridge With the iLet Bionic Pancreas
Published: 2023-06-22 (Crawled : 14:00) - biospace.com/
NVO | News | $126.275 -1.84% 970K
|
Health Technology
|
| O: -0.45%
H: 0.89%
C: 0.13%
fda pancreas clearance insulin
Oak Hill Bio Announces Formation of Board of Directors
Published: 2022-04-12 (Crawled : 13:00) - biospace.com/
TAK | News | $13.26 -0.9% 210K
|
Health Technology
|
| O: 0.07%
H: 0.47%
C: -0.4%
NVO | News | $126.275 -1.84% 970K
|
Health Technology
|
| O: -3.41%
H: 1.22%
C: 0.49%
GSK | News | $40.82 -1.02% 230K
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
SNY | News | $47.1 -1.24% 260K
|
Health Technology
|
| O: -3.25%
H: 0.0%
C: 0.0%
PathAI and Novo Nordisk present AI-powered scoring showing significant reduction of fibrosis following semaglutide treatment in patients with NASH
Published: 2021-11-10 (Crawled : 17:00) - biospace.com/
NVO | News | $126.275 -1.84% 970K
|
Health Technology
|
| O: -0.9%
H: 0.32%
C: -0.81%
treatment ema fibrosis nash
Dicerna Presents PHYOX™2 and Primary Hyperoxaluria Healthcare Utilization Data at American Society of Nephrology (ASN) Kidney Week 2021
Published: 2021-11-04 (Crawled : 18:00) - biospace.com/
NVO | News | $126.275 -1.84% 970K
|
Health Technology
|
| O: 0.06%
H: 0.26%
C: 0.19%
LLY | News | $733.27 -1.67% 470K
|
Health Technology
|
| O: 3.16%
H: 0.0%
C: 0.0%
ALNY | $144.65 -0.97% 90K
|
Health Technology
|
| O: -0.24%
H: 7.69%
C: 7.59%
kidney
Dicerna Reports Positive Top-Line Results From PHYOX™2 Pivotal Clinical Trial of Nedosiran for the Treatment of Primary Hyperoxaluria
Published: 2021-08-05 (Crawled : 21:00) - biospace.com/
NVO | News | $126.275 -1.84% 970K
|
Health Technology
|
| O: 3.16%
H: 1.88%
C: 1.77%
LLY | News | $733.27 -1.67% 470K
|
Health Technology
|
| O: 0.31%
H: 0.85%
C: 0.35%
ALNY | $144.65 -0.97% 90K
|
Health Technology
|
| O: 0.2%
H: 5.7%
C: 5.5%
treatment positive results trial topline
Dicerna Announces FDA Clearance of Investigational New Drug (IND) Application for DCR-AUD for the Treatment of Alcohol Use Disorder
Published: 2021-07-29 (Crawled : 21:00) - biospace.com/
NVO | News | $126.275 -1.84% 970K
|
Health Technology
|
| O: 0.49%
H: 0.26%
C: -0.62%
LLY | News | $733.27 -1.67% 470K
|
Health Technology
|
| O: 0.4%
H: 0.3%
C: -0.88%
ALNY | $144.65 -0.97% 90K
|
Health Technology
|
| O: -0.01%
H: 1.3%
C: -0.14%
new drug alcohol use disorder fda clearance treatment fda drug application clearance
Dicerna Initiates Patient Dosing in ESTRELLA Phase 2 Clinical Trial of Belcesiran for the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
Published: 2021-06-22 (Crawled : 12:15) - biospace.com/
NVO | News | $126.275 -1.84% 970K
|
Health Technology
|
| O: -0.39%
H: 0.27%
C: -0.21%
LLY | News | $733.27 -1.67% 470K
|
Health Technology
|
| O: -0.02%
H: 0.44%
C: -0.53%
ALNY | $144.65 -0.97% 90K
|
Health Technology
|
| O: 0.08%
H: 1.01%
C: 0.9%
disease liver disease treatment phase 2 liver trial
Gainers vs Losers
| 65% | 35% |
Top 10 Gainers
CZOO | $11.44 129.26% 4.6M
|
AMST | $3.4 70.0% 51M
|
Technology Services
BOF | $1.93 64.96% 55M
|
CSSE 4 | $0.23 51.02% 46M
|
Consumer Services
TROO | $1.57 44.04% 2.8M
|
Manufacturing
RILY | $30.87 42.13% 7.8M
|
Finance
LICN | $0.76 35.71% 6.2M
|
MULN | News | $3.53 29.3% 4.8M
|
Information
RBBN 4 | $3.26 26.85% 1.2M
|
Electronic Technology
RCAT | $1.52 26.67% 1.3M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.